Stockscreener 앱 받기
274.51
0.32%
-0.87
시간 외 거래:
274.51
전일 마감가:
$275.38
열려 있는:
$275.4
하루 거래량:
1.33M
Relative Volume:
1.45
시가총액:
$40.19B
수익:
$5.15B
순이익/손실:
$1.40B
주가수익비율:
28.87
EPS:
9.51
순현금흐름:
$1.65B
1주 성능:
-6.54%
1개월 성능:
-1.15%
6개월 성능:
+18.69%
1년 성능:
+12.89%
1일 변동 폭
$271.33
$275.40
1주일 범위
$271.33
$293.58
52주 변동 폭
$199.92
$293.81
Resmed Inc Stock (RMD) Company Profile
명칭
Resmed Inc
전화
(858) 746-2400
주소
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
RMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
274.51 | 40.32B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ISRG
Intuitive Surgical Inc
|
473.30 | 169.86B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
192.98 | 54.82B | 21.39B | 1.61B | 2.55B | 5.56 |
|
ALC
Alcon Inc
|
79.81 | 39.28B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
246.95 | 17.65B | 2.96B | 487.70M | 344.00M | 6.68 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-15 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-19 | 개시 | Morgan Stanley | Overweight |
| 2025-01-16 | 개시 | Goldman | Buy |
| 2025-01-10 | 개시 | Piper Sandler | Neutral |
| 2024-12-13 | 개시 | Stifel | Hold |
| 2024-09-24 | 개시 | Robert W. Baird | Outperform |
| 2024-09-18 | 다운그레이드 | Wolfe Research | Peer Perform → Underperform |
| 2024-09-04 | 다운그레이드 | Needham | Buy → Hold |
| 2024-06-25 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-06-24 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-09-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | 업그레이드 | Needham | Hold → Buy |
| 2023-09-05 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-08-01 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | 개시 | UBS | Buy |
| 2023-04-14 | 개시 | Mizuho | Buy |
| 2023-01-17 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-10-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-20 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-10-12 | 개시 | Jefferies | Hold |
| 2022-09-08 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-08-15 | 다운그레이드 | CLSA | Buy → Outperform |
| 2022-08-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-08-12 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-08-12 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-01-31 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-01-31 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-01-28 | 업그레이드 | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-01-24 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-01-13 | 업그레이드 | CLSA | Outperform → Buy |
| 2022-01-13 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | 업그레이드 | Macquarie | Neutral → Outperform |
| 2021-10-22 | 업그레이드 | CLSA | Underperform → Outperform |
| 2021-08-02 | 다운그레이드 | CLSA | Outperform → Sell |
| 2021-08-02 | 다운그레이드 | Needham | Buy → Hold |
| 2021-07-28 | 업그레이드 | Jefferies | Underperform → Hold |
| 2021-07-26 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-07-14 | 개시 | RBC Capital Mkts | Underperform |
| 2021-06-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-06-22 | 업그레이드 | Macquarie | Neutral → Outperform |
| 2021-06-22 | 개시 | Robert W. Baird | Neutral |
| 2021-06-21 | 재확인 | Needham | Buy |
| 2021-06-16 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-06-09 | 업그레이드 | CLSA | Sell → Outperform |
| 2021-05-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-05-11 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-04-30 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-03-16 | 업그레이드 | Needham | Hold → Buy |
| 2020-11-02 | 업그레이드 | UBS | Neutral → Buy |
| 2020-10-30 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2020-10-27 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-08-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2020-05-01 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-02-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | 개시 | CLSA | Underperform |
| 2020-01-31 | 다운그레이드 | UBS | Buy → Neutral |
| 2020-01-10 | 개시 | Oppenheimer | Perform |
| 2019-11-22 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | 업그레이드 | UBS | Neutral → Buy |
| 2019-07-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-05-06 | 업그레이드 | UBS | Neutral → Buy |
| 2019-04-18 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2019-01-25 | 다운그레이드 | Goldman | Buy → Neutral |
| 2019-01-25 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-10-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | 개시 | Goldman | Buy |
모두보기
Resmed Inc 주식(RMD)의 최신 뉴스
Can ResMed Inc. disrupt its industryGap Down & Expert Approved Momentum Trade Ideas - خودرو بانک
Visual analytics tools that track ResMed Inc. performanceJuly 2025 Update & Consistent Profit Alerts - Newser
Advanced analytics toolkit walkthrough for ResMed Inc.July 2025 PreEarnings & Intraday High Probability Alerts - Newser
Is ResMed Inc.’s growth already priced inJuly 2025 Highlights & Target Return Focused Picks - خودرو بانک
Stock Analysis | ResMed OutlookTechnical Weakness Lingers Amid Mixed Analyst Sentiment - AInvest
Best data tools to analyze ResMed Inc. stockMarket Volume Report & Technical Analysis for Trade Confirmation - Newser
Can technical indicators confirm ResMed Inc.’s reversalWeekly Gains Report & Verified Swing Trading Watchlist - Newser
ResMed Inc. stock trendline breakdown2025 Price Targets & Technical Pattern Based Buy Signals - Newser
Real time breakdown of ResMed Inc. stock performanceMarket Risk Report & Free Reliable Trade Execution Plans - Newser
Should you wait for a breakout in ResMed Inc.July 2025 Summary & Reliable Volume Spike Alerts - Newser
Predicting ResMed Inc. trend using moving averagesGold Moves & Low Risk High Reward Trade Ideas - Newser
What’s next for ResMed Inc. stock priceDip Buying & Verified Momentum Stock Watchlist - Newser
ResMed Inc.’s volatility index tracking explainedStop Loss & Growth Focused Stock Pick Reports - Newser
Long term hold vs stop loss in ResMed Inc.Earnings Summary Report & Community Driven Trade Alerts - Newser
Multi factor analysis applied to ResMed Inc.2025 Breakouts & Breakdowns & Fast Entry and Exit Trade Plans - Newser
Is ResMed Inc. forming a reversal pattern2025 Market Sentiment & Stepwise Entry/Exit Trade Alerts - Newser
What MACD and RSI say about ResMed Inc.Market Activity Report & Real-Time Stock Price Movement Reports - Newser
Regression analysis insights on ResMed Inc. performanceWeekly Profit Report & Verified Trade Idea Suggestions - Newser
Order Flow Trends Show Accumulation in ResMed Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Pattern recognition hints at ResMed Inc. upsideTrade Exit Summary & Daily Growth Stock Tips - Newser
Can ResMed Inc. recover in the next quarterMarket Growth Summary & Stock Portfolio Risk Management - Newser
Visualizing ResMed Inc. stock with heatmapsJuly 2025 Market Mood & Precise Swing Trade Entry Alerts - Newser
What indicators show strength in ResMed Inc.Market Growth Review & Fast Exit and Entry Trade Guides - Newser
What machine learning models say about ResMed Inc.Weekly Trading Summary & AI Optimized Trade Strategies - Newser
Is ResMed Inc. forming a bottoming base2025 Geopolitical Influence & AI Enhanced Trading Signals - Newser
Published on: 2025-08-30 06:38:37 - Newser
Live market analysis of ResMed Inc.2025 Macro Impact & Breakout Confirmation Trade Signals - Newser
Resmed Inc (RMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.47%
자본화:
|
볼륨(24시간):